In our study, we demonstrated that enforcing expression of GLUT3 by CD8+ T cells increases glucose uptake and drives the accumulation of energy reserves in the form of glycogen and lipids, thereby resulting in a favorable metabolic profile, better resistance to cell death and stress/exhaustion, and superior tumor control upon ACT. The gene discussed is SLC2A3; the disease is neoplasm.